In models of humanized AML, it has been demonstrated that IL-3/GM-CSF stimulation is required for the transformation of human hematopoietic cells to AML blasts, and individual patients have shown a reversal from a monoclonal to a polyclonal pattern of MDS with GM-CSF therapy (99). This evidence concerns the gene CSF2 and myelodysplastic syndrome.